Anticonvulsant effect of nalbuphine on maximal electroshock seizure in mice

Indian Journal of Pharmacology

Volumn 30, Issue 5, 1998, Pages 306-310

  Manocha, Anshu ^a   Sharma, K K ^a   Mediratta, P K ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Maximal electroshock seizure; MR2266; Nalbuphine; Naloxone

Indexed keywords

5,9 DIETHYL 2 (3 FURYLMETHYL) 2' HYDROXY 6,7 BENZOMORPHAN; NALBUPHINE; NALOXONE; NALTRINDOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; ELECTRIC SHOCK; EXTENSOR MUSCLE; FEMALE; HINDLIMB; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031761032     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fischer W, Bodewei R, vonVoigtlander PF, Müller M. Anti-convulsant and related effects of U-54494 A in various seizure tests. J Pharmacol Exp Ther 1993;267:163-70.
2. Tortella FC, Robles L, Holaday JW. U50, 488, a highly selective kappa opioid: Anticonvulsant profile in rats. J Pharmacol Exp Ther 1986;237:49-53.
3. Tortella FC. Endogenous opiold peptides and epilepsy : Quieting the seizing brain? Trends Pharmacol Sci 1988; 9:366-72.
4. Tortella FC, Cowan A, Adler MW. Comparison of the anti-convulsant effects of opioid peptides and etorphine in rats after icv administration. Life Sci 1981;10:1039-45.
5. Tortella FC, Cowan A, Adler MW. Studies on the excitatory and inhibitory influence of intracerebroventricularly injected opioids on seizure thresholds in rats. Neuropharmacology 1984;23:749-54.
6. Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: Involvement and interactions of multiple opiate and non- opiate systems. Brain Res Rev 1983;6:197-210.
7. Thomas J, Nores WL, Kenigs V, Olson GA, Olson RD. Picrotoxin-induced seizures modified by morphine and opiate antagonists. Pharmacol Biochem Behav 1993;45:615-7.
8. Cowan A, Geller EB, Adler MW. Classification of opioids on the basis of change in seizure threshold in rats. Science 1979;206:465-7.
9. Albertson TE, Joy RM, Stark LG. Modification of kindled amygdaloid seizures by opiate agonists and antagonists. J Pharmacol Exp Ther 1984;228:620-7.
10. Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR et al. Convulsive effects of systemic administration of the delta opioid agonist BW 373U86 in mice. J Pharmacol Exp Ther 1993;267:888-95.
11. Tortella FC, Robles L, Holaday JW. The anticonvulsant effects of DADLE are primarily mediated by activation of δ opioid receptors: Interactions between δ and μ receptor antagonists. Life Sci 1985;37:497-503.
12. Tortella FC, Robles LE, Holaday JW, Cowan A. A selective role for δ receptors in the regulation of opioid-induced changes in seizure threshold. Life Sci 1983;33:603-6.
13. Manallack DT, Beart PM, Gundlach AL. Psychotomimetic σ-opiates and PCP. Trends Pharmacol Sci 1986;7: 448-51.
14. Berman EF, Adler MW. The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats. Neuropharmacology 1984;23:367-71.
15. Swinyard EA, Brown WC, Goodman LS. Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 1952;106:319-30.
16. Czuczwar SJ, Frey H-H. Effect of morphine and morphinelike analgesics on susceptibility to seizures in mice. Neuropharmacology 1986;25:465-9.
17. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman & Gilman's The pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 521-55.
18. Way WL, Fields HL, Way EL. Opioid analgesics & antagonists. In: Katzung BG, editor. Basic & clinical pharmacology. 7th ed. Stamford: Appleton & Lange, 1998: 496-515.
19. Tortella FC, Robles L, Mosberg HI. Evidence of mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. J Pharmacol Exp Ther 1987; 240:571-7.
20. Frey H-H. Effect of μ- and k-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR2266. Pharmacol Toxicol 1988;62: 150-4.
21. Pick CG, Paul D, Pasternak GW. Nalbuphine, a mixed kappa1 and kappa3 analgesic in mice. J Pharmacol Exp Ther 1992; 262:1044-50.
22. Zimmerman DM, Leander JD, Reel JK, Hynes MD. Use of β- funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands. J Pharmacol Exp Ther 1987;241:374-8.
23. De Souza EB, Schmidt WK, Kuhar MJ. Nalbuphine: An autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic. J Pharmacol Exp Ther 1988; 244:391-402.
24. Clark JA, Liu L, Price M, Hersh B, Edelson M, Pasternak GW. Kappa opiate receptor multiplicity: Evidence for two U50,488- sensitive k1 subtypes and a novel A3 subtype. J Pharmacol Exp Ther 1989; 251:461-8.
25. Traynor JR, Elliott J. δ-Opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol Sci 1993;14: 84-6.
26. Manocha A, Sharma KK, Mediratta PK. The anticonvulsant effect of pentazocine against maximal electroshock seizure in mice. Indian J Pharmacol 1997;29:194-7.